Researchers identify point of epigenetic mutation of hereditary neuroendocrine tumours.

Researchers at the Spanish National Cancer Research Centre (CNIO) have described the presence of mutations in the MDH2 gene, in a family with very rare neuroendocrine tumours associated with a high hereditary component known as pheochromocytomas and paragangliomas that affect the suprarenal and parathyroid glands (groups of chromaffin cells in the central nervous system), respectively. The study is published in the Journal of the National … Continue reading Researchers identify point of epigenetic mutation of hereditary neuroendocrine tumours.